Celgene (CELG) closed the most recent trading day at $87.01, moving -0.45% from the previous trading session. This change was narrower than the S&P 500's 0.53% loss on the day. At the same time, the ...

In the latest trading session, Celgene (CELG) closed at $96.80, marking a -0.32% move from the previous day. This change lagged the S&P 500's 0.06% gain on the day. Meanwhile, the Dow gained 0.16%, ...

“Market volatility has picked up again over the past few weeks. Headlines highlight risks regarding interest rates, the Fed, China, house prices, auto sales, trade wars, and more. Uncertainty abounds.

Is Celgene Corporation (NASDAQ:CELG) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top ...

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on October 31, Celgene Corp.'s Director, Rodman L Drake, ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Celgene (CELG) or Vertex Pharmaceuticals (VRTX). But which of these two stocks is more ...

Forbes contributors publish independent expert analyses and insights. We provide aggregated data on dividend stocks. Nov 24, 2015, 11:12am EST Nov 24, 2015, 11:12am EST This article is more than 10 ...

. The target price for CELG is set to $64. Jefferies & Co says, “Celgene's Revlimid became eligible for a generic challenge since December 27, 2009, so today's Paragraph IV filing should come as no ...

TheStreet’s Jim Cramer says investors need to see money return to the highest-growth names, which have had a shrinking price-to-earnings multiple, as the market moves from the first quarter into the ...